• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于细菌毒力因子干扰宿主细胞因子网络的新型抗结核药物的研发。

Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks.

机构信息

Department of Microbiology and Immunology, Faculty of Medicine, Shimane University, Izumo, Shimane 693-8501, Japan.

出版信息

J Infect Chemother. 2011 Jun;17(3):302-17. doi: 10.1007/s10156-010-0177-y. Epub 2011 Jan 18.

DOI:10.1007/s10156-010-0177-y
PMID:21243398
Abstract

The worldwide increase in the prevalence of tuberculosis (TB), especially multidrug-resistant TB and extensively drug-resistant TB, is an important global health concern, and new effective drugs are urgently needed. Information on the genome of Mycobacterium tuberculosis (MTB) and various mycobacterial virulence genes is leading to the identification of genes that code for new drug targets. Mycobacterium tuberculosis (MTB) is resistant to the antimicrobial mechanisms of host macrophages and can survive and replicate in macrophages for long periods, resulting in a persistent infection. Mycobacterial virulence factors suppress macrophage bactericidal functions partly via their downregulatory effects on the host antimicrobial cytokine networks, consisting of proinflammatory, immunopotentiating, and Th1-inducing cytokines. Thus, for the development of unique drugs that exhibit antimycobacterial action through novel mechanisms, it is reasonable to search for targets among bacterial genes encoding virulence factors which interfere with the host cytokine responses protective to mycobacterial pathogens. In this review, we discuss the profiles of cytokine networks related to host resistance to mycobacteria, including the mechanisms of downregulation of host antimycobacterial immunity due to immunosuppressive cytokines, which are occasionally induced in the advanced stages of TB. We also highlight the development of antituberculous drugs based on bacterial virulence factors interfering with the host antimycobacterial cytokine network.

摘要

全球范围内结核病(TB)的患病率上升,尤其是耐多药结核病和广泛耐药结核病,这是一个重要的全球健康关注点,急需新的有效药物。关于结核分枝杆菌(MTB)基因组和各种分枝杆菌毒力基因的信息,正在导致识别新的药物靶点的基因。结核分枝杆菌(MTB)对宿主巨噬细胞的抗菌机制具有抗性,能够在巨噬细胞中长期存活和复制,导致持续感染。分枝杆菌毒力因子通过下调宿主抗菌细胞因子网络来部分抑制巨噬细胞的杀菌功能,该网络由促炎、免疫增强和 Th1 诱导细胞因子组成。因此,为了开发通过新机制发挥抗分枝杆菌作用的独特药物,有理由在编码干扰宿主对抗分枝杆菌病原体的细胞因子反应的毒力因子的细菌基因中寻找靶标。在这篇综述中,我们讨论了与宿主对分枝杆菌的抗性相关的细胞因子网络的特征,包括由于在结核病的晚期偶尔诱导的免疫抑制细胞因子而导致宿主抗分枝杆菌免疫下调的机制。我们还强调了基于干扰宿主抗分枝杆菌细胞因子网络的细菌毒力因子开发抗结核药物。

相似文献

1
Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks.基于细菌毒力因子干扰宿主细胞因子网络的新型抗结核药物的研发。
J Infect Chemother. 2011 Jun;17(3):302-17. doi: 10.1007/s10156-010-0177-y. Epub 2011 Jan 18.
2
[Prospects for development of new antituberculous drugs].[新型抗结核药物的发展前景]
Kekkaku. 2002 Aug;77(8):573-84.
3
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
4
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.社论:结核杆菌药物靶点的现状与展望以及基于构效关系的抗结核药物设计
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
5
New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.结核病的新方法——基于与巨噬细胞中Toll样受体相关药物靶点的新型药物。
Curr Pharm Des. 2014;20(27):4404-17. doi: 10.2174/1381612819666131118163331.
6
[Prospects for the development of new antituberculous drugs based on the drug targets related to virulence factors interfering with host cytokine networks].基于与干扰宿主细胞因子网络的毒力因子相关的药物靶点开发新型抗结核药物的前景
Kansenshogaku Zasshi. 2012 Nov;86(6):715-22. doi: 10.11150/kansenshogakuzasshi.86.715.
7
[Frontier of mycobacterium research--host vs. mycobacterium].[分枝杆菌研究前沿——宿主与分枝杆菌]
Kekkaku. 2005 Sep;80(9):613-29.
8
The role of epigenetics, bacterial and host factors in progression of Mycobacterium tuberculosis infection.表观遗传学、细菌和宿主因素在结核分枝杆菌感染进展中的作用。
Tuberculosis (Edinb). 2018 Dec;113:200-214. doi: 10.1016/j.tube.2018.10.009. Epub 2018 Oct 30.
9
Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities.一些抗结核药物的现状以及新型抗结核药物的研发,特别提及它们的体外和体内抗菌活性。
Curr Pharm Des. 2006;12(31):4047-70. doi: 10.2174/138161206778743646.
10
Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design.结核分枝杆菌细胞壁相关因子作为主要毒力决定因素:药物发现和设计的当前视角。
Curr Drug Targets. 2017 Nov 30;18(16):1904-1918. doi: 10.2174/1389450118666170711150034.

引用本文的文献

1
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection.非布司他(一种获得 FDA 批准的抗痛风药物)对结核分枝杆菌感染的新型抗菌活性。
Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0076222. doi: 10.1128/aac.00762-22. Epub 2022 Aug 30.
2
Use of Digital Droplet PCR to Detect DNA in Whole Blood-Derived DNA Samples from Patients with Pulmonary and Extrapulmonary Tuberculosis.使用数字液滴PCR检测肺结核和肺外结核患者全血来源DNA样本中的DNA
Front Cell Infect Microbiol. 2017 Aug 11;7:369. doi: 10.3389/fcimb.2017.00369. eCollection 2017.
3
Host Transcriptional Profiles and Immunopathologic Response following Mycobacterium avium subsp. paratuberculosis Infection in Mice.
鸟分枝杆菌副结核亚种感染小鼠后的宿主转录谱及免疫病理反应
PLoS One. 2015 Oct 6;10(10):e0138770. doi: 10.1371/journal.pone.0138770. eCollection 2015.
4
Mycobacterial phylogenomics: an enhanced method for gene turnover analysis reveals uneven levels of gene gain and loss among species and gene families.分枝杆菌系统发育基因组学:一种用于基因更替分析的改进方法揭示了物种和基因家族间基因获得与丢失水平的不均衡。
Genome Biol Evol. 2014 Jun 5;6(6):1454-65. doi: 10.1093/gbe/evu117.
5
Ion-pair chromatography for simultaneous analysis of ethionamide and pyrazinamide from their porous microparticles.离子对色谱法用于从多孔微球中同时分析乙胺丁醇和吡嗪酰胺。
AAPS PharmSciTech. 2013 Dec;14(4):1313-20. doi: 10.1208/s12249-013-0025-3. Epub 2013 Aug 30.
6
The polyphosphate kinase gene ppk2 is required for Mycobacterium tuberculosis inorganic polyphosphate regulation and virulence.多聚磷酸盐激酶基因 ppk2 是结核分枝杆菌无机多聚磷酸盐调控和毒力所必需的。
mBio. 2013 May 21;4(3):e00039-13. doi: 10.1128/mBio.00039-13.
7
Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis.肿瘤坏死因子-α、干扰素-γ和白细胞介素-10在肺结核发病中的作用
Pulm Med. 2012;2012:745483. doi: 10.1155/2012/745483. Epub 2012 Nov 28.
8
Characteristics of suppressor macrophages induced by mycobacterial and protozoal infections in relation to alternatively activated M2 macrophages.分枝杆菌和原生动物感染诱导的抑制性巨噬细胞与替代性活化的M2巨噬细胞相关的特征。
Clin Dev Immunol. 2012;2012:635451. doi: 10.1155/2012/635451. Epub 2012 May 15.